纽瑞克斯制药

最新新闻

• 评级变动
  H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/6/11
• RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/12
• 评级变动
  Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/5/16
• 评级变动
  Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/6/15
• Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Piper Sandler Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Nurix Therapeutics (NRIX) and Immunic (IMUX)
  TipRanks · 2026/6/9
• 评级变动
  Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  Truist Financial Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/15
• Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $45
  \u5e02\u573a\u8d44\u8baf · 2026/6/9
• A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/11
• 评级变动
  A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $32
  \u5e02\u573a\u8d44\u8baf · 2026/6/10

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。